Skip to content

To find relationship between a Subjective scale (RASS) & an Objective scale (PSI) for assessment of sedation in critically ill patients.

Relationship between Patient State Index & Richmond Agitation Sedation Scale for sedation in critically ill patients. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053988
Enrollment
35
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: I00-I99- Diseases of the circulatory system Health Condition 3: K00-K95- Diseases of the digestive system Health Condition 4: H60-H95- Diseases of the ear and mastoid process Health Condition 5: H00-H59- Diseases of the eye and adnexa Health Condition 6: N00-N99- Diseases of the genitourinary system Health Condition 7: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 8

Interventions

None listed

Sponsors

Lady Hardinge Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who are more than 18yrs of age, admitted in ICU & requiring sedation

Exclusion criteria

Exclusion criteria: 1. Patients receiving muscle relaxants 2. Patients with head injuries 3. Patients having any focal brain disease or abnormal electrical brain activity

Design outcomes

Primary

MeasureTime frame
Correlation between PSI & RASS using Pearson/Spearmans correlation coefficientTimepoint: 48hrs

Secondary

MeasureTime frame
Value of PSI corresponding to RASS 0to-3 using receiver operating characteristic (AUROC) curve analysisTimepoint: 4hrs

Countries

India

Contacts

Public ContactDr Nishant Kumar

Lady Hardinge Medical College

kumarnishant@yahoo.co.uk9811934659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026